Jensen J, Omar M, Kistorp C, Poulsen MK, et al. Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial. Am Heart J 2020;228:47-56.
PMID: 32798787